Aclaris Therapeutics ACRS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's net income?
- Aclaris Therapeutics (ACRS) reported net income of -$19.82M in Q1 2026.
- How has Aclaris Therapeutics's net income changed year-over-year?
- Aclaris Therapeutics's net income decreased by 31.4% year-over-year, from -$15.09M to -$19.82M.
- What is the long-term trend for Aclaris Therapeutics's net income?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's net income has grown at a -8.1% compound annual growth rate (CAGR), from -$90.87M to -$64.92M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.